| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCC1 SCN11A ATP6V0A1 IPO8 MRS2 SLC26A2 SLC38A4 SLC43A1 TUSC3 GJC2 PKD1L2 SLC13A2 SLC10A7 NDUFS4 SLC5A1 ITPR1 ITPR3 SLC22A18 SLC13A4 SLC30A5 ABCB9 SLC45A3 KCNH1 KCNJ4 SLCO2A1 SLC22A4 SCN4A ABCC12 TRPM1 SLC38A3 SLC38A8 ATP6V0A2 | 4.09e-09 | 1180 | 169 | 32 | GO:0022857 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC1 ATP6V0A1 IPO8 SLC26A2 SLC38A4 SLC13A2 SLC10A7 NDUFS4 SLC5A1 SLC22A18 SLC13A4 SLC30A5 ABCB9 SLC45A3 SLCO2A1 SLC22A4 ABCC12 SLC38A3 ATP6V0A2 | 2.43e-08 | 477 | 169 | 19 | GO:0022804 |
| GeneOntologyMolecularFunction | transporter activity | ABCC1 SCN11A ATP6V0A1 IPO8 MRS2 SLC26A2 SLC38A4 SLC43A1 TUSC3 GJC2 PKD1L2 SLC13A2 SLC10A7 NDUFS4 SLC5A1 ITPR1 ITPR3 SLC22A18 SLC13A4 SLC30A5 ABCB9 SLC45A3 KCNH1 KCNJ4 SLCO2A1 SLC22A4 SCN4A ABCC12 TRPM1 SLC38A3 SLC38A8 ATP6V0A2 | 3.33e-08 | 1289 | 169 | 32 | GO:0005215 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SCN11A ATP6V0A1 MRS2 SLC38A4 TUSC3 PKD1L2 SLC13A2 NDUFS4 SLC5A1 ITPR1 ITPR3 SLC13A4 SLC30A5 SLC45A3 KCNH1 KCNJ4 SCN4A TRPM1 SLC38A3 ATP6V0A2 | 3.75e-07 | 627 | 169 | 20 | GO:0022890 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ABCC1 SCN11A ATP6V0A1 MRS2 SLC26A2 SLC38A4 TUSC3 PKD1L2 SLC13A2 NDUFS4 SLC5A1 ITPR1 ITPR3 SLC13A4 SLC30A5 SLC45A3 KCNH1 KCNJ4 SCN4A TRPM1 SLC38A3 ATP6V0A2 | 4.68e-07 | 758 | 169 | 22 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SCN11A ATP6V0A1 MRS2 SLC38A4 TUSC3 PKD1L2 SLC13A2 NDUFS4 SLC5A1 ITPR1 ITPR3 SLC13A4 SLC30A5 SLC45A3 KCNH1 KCNJ4 SCN4A TRPM1 SLC38A3 ATP6V0A2 | 9.19e-07 | 664 | 169 | 20 | GO:0008324 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SCN11A MRS2 SLC38A4 TUSC3 PKD1L2 SLC13A2 SLC5A1 ITPR1 ITPR3 SLC13A4 SLC30A5 KCNH1 KCNJ4 SCN4A TRPM1 SLC38A3 | 2.25e-06 | 465 | 169 | 16 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SCN11A ATP6V0A1 MRS2 SLC26A2 SLC38A4 TUSC3 PKD1L2 SLC13A2 NDUFS4 SLC5A1 ITPR1 ITPR3 SLC13A4 SLC30A5 SLC45A3 KCNH1 KCNJ4 SCN4A TRPM1 SLC38A3 ATP6V0A2 | 3.71e-06 | 793 | 169 | 21 | GO:0015075 |
| GeneOntologyMolecularFunction | symporter activity | SLC38A4 SLC13A2 SLC10A7 SLC5A1 SLC22A18 SLC13A4 SLC45A3 SLC22A4 SLC38A3 | 5.38e-06 | 150 | 169 | 9 | GO:0015293 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC26A2 SLC38A4 SLC13A2 SLC10A7 SLC5A1 SLC22A18 SLC13A4 SLC30A5 SLC45A3 SLCO2A1 SLC22A4 SLC38A3 | 8.65e-06 | 296 | 169 | 12 | GO:0015291 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.38e-05 | 18 | 169 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.43e-05 | 37 | 169 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 8.65e-05 | 28 | 169 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate phosphatase activity | 2.02e-04 | 14 | 169 | 3 | GO:0004438 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | ABCC1 SLC26A2 SLC38A4 SLC43A1 SLC13A2 SLC10A7 SLC22A18 SLCO2A1 SLC38A3 SLC38A8 | 2.04e-04 | 293 | 169 | 10 | GO:0008514 |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 2.12e-04 | 3 | 169 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | phosphatidylinositol monophosphate phosphatase activity | 2.51e-04 | 15 | 169 | 3 | GO:0052744 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | ATP6V0A1 SLC38A4 SLC13A2 NDUFS4 SLC5A1 SLC13A4 SLC30A5 SLC45A3 SLC38A3 ATP6V0A2 | 2.53e-04 | 301 | 169 | 10 | GO:0022853 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 3.08e-04 | 16 | 169 | 3 | GO:0106018 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.32e-04 | 109 | 169 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | ABCC1 SLC26A2 SLC38A4 SLC43A1 SLC13A2 SLC10A7 SLC38A3 SLC38A8 | 3.91e-04 | 207 | 169 | 8 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | ABCC1 SLC26A2 SLC38A4 SLC43A1 SLC13A2 SLC10A7 SLC38A3 SLC38A8 | 4.04e-04 | 208 | 169 | 8 | GO:0005342 |
| GeneOntologyMolecularFunction | MAP kinase kinase activity | 4.43e-04 | 18 | 169 | 3 | GO:0004708 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 5.30e-04 | 119 | 169 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 6.24e-04 | 81 | 169 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 6.44e-04 | 171 | 169 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 6.65e-04 | 47 | 169 | 4 | GO:0004712 | |
| GeneOntologyMolecularFunction | inhibin binding | 7.00e-04 | 5 | 169 | 2 | GO:0034711 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC1 ATP6V0A1 IPO8 DYNC2H1 RNF213 TRAP1 MDN1 ABCB9 DNAH17 ABCC12 DNAH5 DNAH9 VCP ATP6V0A2 | 7.52e-04 | 614 | 169 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 8.16e-04 | 178 | 169 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.00e-03 | 239 | 169 | 8 | GO:0031406 | |
| GeneOntologyMolecularFunction | organic acid binding | 1.48e-03 | 254 | 169 | 8 | GO:0043177 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate phosphatase activity | 1.50e-03 | 27 | 169 | 3 | GO:0034593 | |
| GeneOntologyMolecularFunction | neutral L-amino acid:sodium symporter activity | 1.93e-03 | 8 | 169 | 2 | GO:0005295 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.00e-03 | 105 | 169 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 2.04e-03 | 30 | 169 | 3 | GO:0052866 | |
| GeneOntologyMolecularFunction | activin receptor activity | 2.47e-03 | 9 | 169 | 2 | GO:0017002 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.94e-03 | 70 | 169 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 3.10e-03 | 71 | 169 | 4 | GO:0015179 | |
| GeneOntologyBiologicalProcess | positive regulation of activin receptor signaling pathway | 2.73e-05 | 8 | 165 | 3 | GO:0032927 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ABCC1 SCN11A ATP6V0A1 MRS2 SLC26A2 SLC38A4 TUSC3 GJC2 PKD1L2 SLC13A2 SLC10A7 SLC5A1 ITPR1 ITPR3 SLC22A18 CORO1A SLC13A4 SLC30A5 KCNH1 KCNJ4 SLC22A4 SCN4A TRPM1 SLC38A3 HTT ATP6V0A2 | 3.57e-05 | 1374 | 165 | 26 | GO:0006811 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SCN11A ATP6V0A1 MRS2 SLC38A4 TUSC3 GJC2 PKD1L2 SLC13A2 SLC5A1 ITPR1 ITPR3 CORO1A SLC13A4 SLC30A5 KCNH1 KCNJ4 SCN4A TRPM1 HTT ATP6V0A2 | 4.96e-05 | 922 | 165 | 20 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SCN11A ATP6V0A1 MRS2 SLC38A4 TUSC3 GJC2 PKD1L2 SLC13A2 SLC10A7 SLC5A1 ITPR1 ITPR3 CORO1A SLC13A4 SLC30A5 KCNH1 KCNJ4 SLC22A4 SCN4A TRPM1 SLC38A3 HTT ATP6V0A2 | 5.04e-05 | 1157 | 165 | 23 | GO:0006812 |
| GeneOntologyBiologicalProcess | metal ion transport | SCN11A MRS2 SLC38A4 TUSC3 GJC2 PKD1L2 SLC13A2 SLC10A7 SLC5A1 ITPR1 ITPR3 CORO1A SLC13A4 SLC30A5 KCNH1 KCNJ4 SLC22A4 SCN4A TRPM1 SLC38A3 HTT | 5.07e-05 | 1000 | 165 | 21 | GO:0030001 |
| GeneOntologyBiologicalProcess | endoplasmic reticulum stress-induced pre-emptive quality control | 6.36e-05 | 2 | 165 | 2 | GO:0061857 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SCN11A ATP6V0A1 MRS2 SLC26A2 SLC38A4 TUSC3 GJC2 PKD1L2 SLC13A2 SLC5A1 ITPR1 ITPR3 CORO1A SLC13A4 SLC30A5 KCNH1 KCNJ4 SCN4A TRPM1 HTT ATP6V0A2 | 6.45e-05 | 1017 | 165 | 21 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SCN11A ATP6V0A1 MRS2 SLC38A4 TUSC3 GJC2 PKD1L2 SLC13A2 SLC5A1 ITPR1 ITPR3 CORO1A SLC13A4 SLC30A5 KCNH1 KCNJ4 SCN4A TRPM1 HTT ATP6V0A2 | 6.67e-05 | 942 | 165 | 20 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ABCC1 SCN11A ATP6V0A1 MRS2 SLC26A2 SLC38A4 TUSC3 GJC2 PKD1L2 SLC13A2 SLC5A1 ITPR1 ITPR3 CORO1A SLC13A4 SLC30A5 KCNH1 KCNJ4 SCN4A TRPM1 HTT ATP6V0A2 | 8.31e-05 | 1115 | 165 | 22 | GO:0034220 |
| GeneOntologyBiologicalProcess | import across plasma membrane | ABCC1 SLC38A4 SLC43A1 SLC5A1 SLC30A5 KCNJ4 SLC22A4 TRPM1 SLC38A3 | 1.01e-04 | 230 | 165 | 9 | GO:0098739 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | LPCAT1 HLA-DPB1 HLA-DQB1 SLC43A1 TUSC3 SLC10A7 REEP3 SACM1L ITPR1 ITPR3 RNF170 ERG28 SLC30A5 ABCB9 RNF103 DERL3 SYNE2 UGT2B15 UGT2B17 ABCC12 TRPM1 OTULINL HSD17B2 HACD1 VCP | 5.34e-05 | 1293 | 171 | 25 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | LPCAT1 HLA-DPB1 HLA-DQB1 SLC43A1 TUSC3 SLC10A7 REEP3 SACM1L ITPR1 ITPR3 RNF170 ERG28 SLC30A5 ABCB9 RNF103 DERL3 SYNE2 UGT2B15 UGT2B17 ABCC12 TRPM1 OTULINL HSD17B2 HACD1 VCP | 5.75e-05 | 1299 | 171 | 25 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | LPCAT1 HLA-DPB1 HLA-DQB1 SLC43A1 TUSC3 SLC10A7 REEP3 SACM1L ITPR1 ITPR3 RNF170 ERG28 SLC30A5 ABCB9 RNF103 DERL3 SYNE2 UGT2B15 UGT2B17 ABCC12 TRPM1 OTULINL HSD17B2 HACD1 VCP | 8.09e-05 | 1327 | 171 | 25 | GO:0042175 |
| GeneOntologyCellularComponent | outer dynein arm | 1.12e-04 | 12 | 171 | 3 | GO:0036157 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 3.14e-04 | 40 | 171 | 4 | GO:0005640 | |
| GeneOntologyCellularComponent | apical plasma membrane | ABCC1 SLC26A2 SLC43A1 SI TMEM235 SLC13A2 SLC5A1 ITPR3 SLC22A18 SLC30A5 SLC22A4 SLC38A3 | 6.94e-04 | 487 | 171 | 12 | GO:0016324 |
| GeneOntologyCellularComponent | nuclear envelope | DPY19L2 IPO8 NUP85 ITPR1 ITPR3 SLC22A18 KCNH1 SYNE2 UGT2B15 UGT2B17 NUP188 WDFY3 OTULINL | 7.26e-04 | 560 | 171 | 13 | GO:0005635 |
| GeneOntologyCellularComponent | activin receptor complex | 9.77e-04 | 6 | 171 | 2 | GO:0048179 | |
| GeneOntologyCellularComponent | dynein complex | 9.94e-04 | 54 | 171 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.08e-03 | 25 | 171 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | apical part of cell | ABCC1 DYNC2H1 SLC26A2 SLC43A1 SI TMEM235 SLC13A2 SLC5A1 ITPR3 SLC22A18 SLC30A5 SLC22A4 SLC38A3 | 1.20e-03 | 592 | 171 | 13 | GO:0045177 |
| MousePheno | thin retina outer plexiform layer | 5.91e-06 | 27 | 138 | 5 | MP:0008519 | |
| Domain | ARM-type_fold | DOCK2 DOCK3 RALGAPA1 IPO8 RTTN ITPR1 FOCAD HEATR9 USP35 NUP188 WDFY3 AGBL1 TBCD HTT | 1.83e-06 | 339 | 164 | 14 | IPR016024 |
| Domain | AAA | 5.15e-06 | 144 | 164 | 9 | SM00382 | |
| Domain | AAA+_ATPase | 5.15e-06 | 144 | 164 | 9 | IPR003593 | |
| Domain | ATPase_dyneun-rel_AAA | 5.36e-06 | 14 | 164 | 4 | IPR011704 | |
| Domain | AAA_5 | 5.36e-06 | 14 | 164 | 4 | PF07728 | |
| Domain | Aa_trans | 1.25e-05 | 17 | 164 | 4 | PF01490 | |
| Domain | AA_transpt_TM | 1.25e-05 | 17 | 164 | 4 | IPR013057 | |
| Domain | DHC_N1 | 3.60e-05 | 8 | 164 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 3.60e-05 | 8 | 164 | 3 | IPR013594 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.25e-04 | 14 | 164 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.25e-04 | 14 | 164 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.25e-04 | 14 | 164 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.25e-04 | 14 | 164 | 3 | PF08393 | |
| Domain | MT | 2.25e-04 | 14 | 164 | 3 | PF12777 | |
| Domain | AAA_8 | 2.25e-04 | 14 | 164 | 3 | PF12780 | |
| Domain | DUF3522 | 2.29e-04 | 3 | 164 | 2 | IPR021910 | |
| Domain | InsP3_rcpt-bd | 2.29e-04 | 3 | 164 | 2 | IPR000493 | |
| Domain | DUF3522 | 2.29e-04 | 3 | 164 | 2 | PF12036 | |
| Domain | DHC_fam | 2.80e-04 | 15 | 164 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.80e-04 | 15 | 164 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.80e-04 | 15 | 164 | 3 | IPR004273 | |
| Domain | V_ATPase_I | 4.55e-04 | 4 | 164 | 2 | PF01496 | |
| Domain | V-type_ATPase_116kDa_su_euka | 4.55e-04 | 4 | 164 | 2 | IPR026028 | |
| Domain | V-ATPase_116kDa_su | 4.55e-04 | 4 | 164 | 2 | IPR002490 | |
| Domain | Ion_trans_dom | 5.11e-04 | 114 | 164 | 6 | IPR005821 | |
| Domain | Ion_trans | 5.11e-04 | 114 | 164 | 6 | PF00520 | |
| Domain | ARM-like | 6.51e-04 | 270 | 164 | 9 | IPR011989 | |
| Domain | DOCK_N | 7.53e-04 | 5 | 164 | 2 | PF16172 | |
| Domain | Na/sul_symport | 7.53e-04 | 5 | 164 | 2 | IPR001898 | |
| Domain | DOCK_N | 7.53e-04 | 5 | 164 | 2 | IPR032376 | |
| Domain | Na_sulph_symp | 7.53e-04 | 5 | 164 | 2 | PF00939 | |
| Domain | RIH_assoc-dom | 1.12e-03 | 6 | 164 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.12e-03 | 6 | 164 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.12e-03 | 6 | 164 | 2 | PF08454 | |
| Domain | RIH_dom | 1.12e-03 | 6 | 164 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.12e-03 | 6 | 164 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.12e-03 | 6 | 164 | 2 | IPR015925 | |
| Domain | - | 1.12e-03 | 6 | 164 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.12e-03 | 6 | 164 | 2 | PF01365 | |
| Domain | ABC_membrane | 1.17e-03 | 24 | 164 | 3 | PF00664 | |
| Domain | ABC_TM1F | 1.85e-03 | 28 | 164 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 1.85e-03 | 28 | 164 | 3 | IPR011527 | |
| Domain | MHC_II_b_N | 2.07e-03 | 8 | 164 | 2 | PD000328 | |
| Domain | MHC_II_b_N | 2.65e-03 | 9 | 164 | 2 | IPR000353 | |
| Domain | MHC_II_beta | 2.65e-03 | 9 | 164 | 2 | SM00921 | |
| Domain | MHC_II_beta | 2.65e-03 | 9 | 164 | 2 | PF00969 | |
| Domain | Na_channel_asu | 3.29e-03 | 10 | 164 | 2 | IPR001696 | |
| Domain | MIR | 3.29e-03 | 10 | 164 | 2 | PF02815 | |
| Domain | MIR_motif | 3.29e-03 | 10 | 164 | 2 | IPR016093 | |
| Domain | Na_trans_assoc | 3.29e-03 | 10 | 164 | 2 | IPR010526 | |
| Domain | Activin_recp | 3.29e-03 | 10 | 164 | 2 | PF01064 | |
| Domain | Na_trans_assoc | 3.29e-03 | 10 | 164 | 2 | PF06512 | |
| Domain | MIR | 3.29e-03 | 10 | 164 | 2 | PS50919 | |
| Domain | MIR | 3.29e-03 | 10 | 164 | 2 | SM00472 | |
| Domain | Activin_recp | 3.29e-03 | 10 | 164 | 2 | IPR000472 | |
| Domain | DHR-1_domain | 4.00e-03 | 11 | 164 | 2 | IPR027007 | |
| Domain | DHR_2 | 4.00e-03 | 11 | 164 | 2 | PS51651 | |
| Domain | DHR_1 | 4.00e-03 | 11 | 164 | 2 | PS51650 | |
| Domain | DHR-2 | 4.00e-03 | 11 | 164 | 2 | PF06920 | |
| Domain | DOCK | 4.00e-03 | 11 | 164 | 2 | IPR026791 | |
| Domain | DOCK_C | 4.00e-03 | 11 | 164 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 4.00e-03 | 11 | 164 | 2 | PF14429 | |
| Domain | DHR-2 | 4.00e-03 | 11 | 164 | 2 | IPR027357 | |
| Domain | Prot_kinase_dom | EPHB6 MAK TRIB2 STK17B PBK ACVR2A ACVR2B STK33 MAP2K1 MAP2K3 EPHA10 | 4.01e-03 | 489 | 164 | 11 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | EPHB6 MAK TRIB2 STK17B PBK ACVR2A ACVR2B STK33 MAP2K1 MAP2K3 EPHA10 | 4.26e-03 | 493 | 164 | 11 | PS50011 |
| Domain | MFS_1 | 4.72e-03 | 77 | 164 | 4 | PF07690 | |
| Domain | MFS | 4.72e-03 | 77 | 164 | 4 | IPR011701 | |
| Domain | TGFB_receptor | 4.77e-03 | 12 | 164 | 2 | IPR000333 | |
| Domain | ABC_transporter_CS | 5.94e-03 | 42 | 164 | 3 | IPR017871 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 6.51e-03 | 14 | 164 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 6.51e-03 | 14 | 164 | 2 | PS00790 | |
| Domain | MHC_II_a/b_N | 6.51e-03 | 14 | 164 | 2 | IPR014745 | |
| Domain | Tyr_kinase_rcpt_V_CS | 6.51e-03 | 14 | 164 | 2 | IPR001426 | |
| Domain | Myotubularin-like_Pase_dom | 6.51e-03 | 14 | 164 | 2 | IPR010569 | |
| Domain | EphA2_TM | 6.51e-03 | 14 | 164 | 2 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 6.51e-03 | 14 | 164 | 2 | IPR001090 | |
| Domain | Eph_TM | 6.51e-03 | 14 | 164 | 2 | IPR027936 | |
| Domain | EPH_lbd | 6.51e-03 | 14 | 164 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 6.51e-03 | 14 | 164 | 2 | PF01404 | |
| Domain | - | 6.51e-03 | 14 | 164 | 2 | 3.10.320.10 | |
| Domain | PPASE_MYOTUBULARIN | 6.51e-03 | 14 | 164 | 2 | PS51339 | |
| Domain | Myotubularin_fam | 6.51e-03 | 14 | 164 | 2 | IPR030564 | |
| Domain | Tyr_kinase_ephrin_rcpt | 6.51e-03 | 14 | 164 | 2 | IPR016257 | |
| Domain | Myotub-related | 6.51e-03 | 14 | 164 | 2 | PF06602 | |
| Domain | EPH_LBD | 6.51e-03 | 14 | 164 | 2 | PS51550 | |
| Domain | MFS_dom | 6.61e-03 | 134 | 164 | 5 | IPR020846 | |
| Domain | Pkinase | 6.61e-03 | 381 | 164 | 9 | PF00069 | |
| Domain | Kinase-like_dom | EPHB6 MAK TRIB2 STK17B PBK ACVR2A ACVR2B STK33 MAP2K1 MAP2K3 EPHA10 | 8.48e-03 | 542 | 164 | 11 | IPR011009 |
| Domain | GRAM | 8.48e-03 | 16 | 164 | 2 | SM00568 | |
| Domain | ABC_tran | 8.61e-03 | 48 | 164 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 8.61e-03 | 48 | 164 | 3 | PS50893 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC1 ATP6V0A1 MRS2 SLC26A2 SLC38A4 SLC43A1 TUSC3 PSMD12 SLC13A2 SLC5A1 SLC22A18 SLC13A4 SLC30A5 ABCB9 SLC45A3 SLCO2A1 DERL3 SLC22A4 TRPM1 SLC38A3 VCP ATP6V0A2 | 1.42e-07 | 681 | 126 | 22 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC1 ATP6V0A1 MRS2 SLC26A2 SLC38A4 SLC43A1 TUSC3 PSMD12 SLC13A2 SLC5A1 SLC22A18 SLC13A4 SLC30A5 ABCB9 SLC45A3 SLCO2A1 DERL3 SLC22A4 TRPM1 SLC38A3 VCP ATP6V0A2 | 5.37e-07 | 736 | 126 | 22 | M27287 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC26A2 SLC38A4 SLC43A1 SLC13A2 SLC5A1 SLC22A18 SLC13A4 SLC30A5 SLC45A3 SLCO2A1 SLC22A4 SLC38A3 | 1.45e-06 | 238 | 126 | 12 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC26A2 SLC38A4 SLC43A1 SLC13A2 SLC5A1 SLC22A18 SLC13A4 SLC30A5 SLC45A3 SLCO2A1 SLC22A4 SLC38A3 | 2.32e-06 | 249 | 126 | 12 | M5988 |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | NUP85 SLC26A2 PSMD12 SLC5A1 SLC22A18 SLCO2A1 DERL3 NUP188 VCP | 2.96e-05 | 177 | 126 | 9 | M27476 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPN3 DOCK3 NUP85 CTC1 TMEM8B POLR2A RTTN ITPR3 FOCAD DIP2A PHLDB1 KMT2D ARAP3 MDN1 SLC45A3 MTHFR MICAL3 DEPDC5 NUP188 WDFY3 CPVL TBCD HTT | 6.05e-09 | 1105 | 171 | 23 | 35748872 |
| Pubmed | LPCAT1 ATP6V0A1 SACM1L ITPR3 RNF170 S100A9 SLC30A5 GLA RNF103 BAG6 ATP6V0A2 | 2.71e-08 | 235 | 171 | 11 | 32614325 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 5.00e-08 | 104 | 171 | 8 | 31240132 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ABCC1 LPCAT1 ATP6V0A1 NUP85 DYNC2H1 SLC43A1 TMEM59 NDUFS4 EXOC8 SACM1L ITPR3 RNF170 GLA NUP188 OTULINL BAG6 VARS1 VCP TBCD | 2.26e-07 | 942 | 171 | 19 | 31073040 |
| Pubmed | 4.65e-07 | 4 | 171 | 3 | 21610068 | ||
| Pubmed | 1.16e-06 | 5 | 171 | 3 | 11882656 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | DPY19L2 MICOS13 DYNC2H1 SLC26A2 TUSC3 RNF213 PSMD12 ACVR2A FOCAD MDN1 SLC30A5 GCLC DERL3 NUP188 SGSM3 WDFY3 ST8SIA4 BAG6 ATP6V0A2 | 1.34e-06 | 1061 | 171 | 19 | 33845483 |
| Pubmed | 2.31e-06 | 6 | 171 | 3 | 15451561 | ||
| Pubmed | 2.31e-06 | 6 | 171 | 3 | 21365123 | ||
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 31178125 | ||
| Pubmed | 4.70e-06 | 87 | 171 | 6 | 12465718 | ||
| Pubmed | DOCK2 GLIPR1 ABCC1 LPCAT1 NUP85 HLA-DPB1 HLA-DQB1 RNF213 PSMD12 EXOC8 ITPR1 ITPR3 SLC22A18 CORO1A TRAP1 MDN1 NUP188 MAP2K3 BAG6 | 5.37e-06 | 1168 | 171 | 19 | 19946888 | |
| Pubmed | 6.42e-06 | 8 | 171 | 3 | 26565908 | ||
| Pubmed | 7.32e-06 | 143 | 171 | 7 | 20424473 | ||
| Pubmed | LPCAT1 MRS2 MICOS13 TFAM NDUFS4 SACM1L IVD TRAP1 MDN1 MICAL3 FAHD1 MAP2K1 MAP2K3 CPVL | 8.36e-06 | 686 | 171 | 14 | 28380382 | |
| Pubmed | Refining the association of MHC with multiple sclerosis in African Americans. | 9.60e-06 | 9 | 171 | 3 | 20466734 | |
| Pubmed | 1.40e-05 | 30 | 171 | 4 | 16454711 | ||
| Pubmed | EPHB6 BIRC8 ATP6V0A1 POLR2A KEAP1 SACM1L MMP25 KCNH1 DNAH17 MTMR2 MAP2K1 DNAH5 HACD1 ATP6V0A2 | 1.67e-05 | 730 | 171 | 14 | 34857952 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 32660355 | ||
| Pubmed | [Sequencing-based typing of HLA-DPB1 and DQB1 exon 2 in patients with type 1 diabetes mellitus]. | 2.40e-05 | 2 | 171 | 2 | 11592043 | |
| Pubmed | HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition. | 2.40e-05 | 2 | 171 | 2 | 26180102 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 15890645 | ||
| Pubmed | Some but not all of HLA-II alleles are associated with cervical cancer in Chinese women. | 2.40e-05 | 2 | 171 | 2 | 19027490 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 1909870 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 24121496 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 24267955 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 22170718 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 25817040 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 7559486 | ||
| Pubmed | Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5. | 2.40e-05 | 2 | 171 | 2 | 3105095 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 17848572 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 20843799 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 20614846 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 27496708 | ||
| Pubmed | Expression of activin receptor II and IIB mRNA isoforms in mouse reproductive organs and oocytes. | 2.40e-05 | 2 | 171 | 2 | 8049070 | |
| Pubmed | The ATPase VCP/p97 functions as a disaggregase against toxic Huntingtin-exon1 aggregates. | 2.40e-05 | 2 | 171 | 2 | 30069866 | |
| Pubmed | New susceptibility variants to narcolepsy identified in HLA class II region. | 2.40e-05 | 2 | 171 | 2 | 25256355 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 17698910 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 7748787 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 19103205 | ||
| Pubmed | Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor. | 2.40e-05 | 2 | 171 | 2 | 8663526 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 28036256 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 18652916 | ||
| Pubmed | Photoreceptor Protection by Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF). | 2.40e-05 | 2 | 171 | 2 | 29687079 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 1374893 | ||
| Pubmed | Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation. | 2.40e-05 | 2 | 171 | 2 | 3117546 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 23453247 | ||
| Pubmed | Formation and activation by phosphorylation of activin receptor complexes. | 2.40e-05 | 2 | 171 | 2 | 8721982 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 28659341 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 20813840 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 12721173 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 28228532 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 1318045 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 15666817 | ||
| Pubmed | Characterization of type II activin receptors. Binding, processing, and phosphorylation. | 2.40e-05 | 2 | 171 | 2 | 8395525 | |
| Pubmed | Distinct roles of inositol 1,4,5-trisphosphate receptor types 1 and 3 in Ca2+ signaling. | 2.40e-05 | 2 | 171 | 2 | 14707143 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | NUP85 POLR2A PBK MTMR1 KEAP1 TFAM S100A9 NUP188 CPVL BAG6 VARS1 VCP | 2.83e-05 | 571 | 171 | 12 | 37167062 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | B3GALNT1 GLIPR1 UBR2 ABCC1 ATP6V0A1 TMEM59 PBK RNF213 SACM1L ITPR1 RNF170 ERG28 GLA MANF CPVL VCP HTT ATP6V0A2 | 2.86e-05 | 1201 | 171 | 18 | 35696571 |
| Pubmed | 3.35e-05 | 322 | 171 | 9 | 26514267 | ||
| Pubmed | 3.65e-05 | 38 | 171 | 4 | 19574343 | ||
| Pubmed | 4.09e-05 | 14 | 171 | 3 | 9373155 | ||
| Pubmed | 6.11e-05 | 84 | 171 | 5 | 15123239 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 10874040 | ||
| Pubmed | Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects. | 7.19e-05 | 3 | 171 | 2 | 20191588 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 20395455 | ||
| Pubmed | Cataloguing the dead: breathing new life into pseudokinase research. | 7.19e-05 | 3 | 171 | 2 | 32053275 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 19572376 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 14738881 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 17437169 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 33929277 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 37146698 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 16648306 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 12823769 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 18547250 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 36350267 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 11413485 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 26385605 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 19439981 | ||
| Pubmed | Chromosomal localization of four MAPK signaling cascade genes: MEK1, MEK3, MEK4 and MEKK5. | 7.19e-05 | 3 | 171 | 2 | 9465908 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 26009177 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 27116456 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 11532022 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 10997882 | ||
| Pubmed | Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning. | 7.19e-05 | 3 | 171 | 2 | 12414726 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 31815282 | ||
| Pubmed | Receptor-activated single channels in intact human platelets. | 7.19e-05 | 3 | 171 | 2 | 1693919 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 23053953 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 23955339 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 17513705 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 31979185 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 10702241 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 7.19e-05 | 3 | 171 | 2 | 24904548 | |
| Pubmed | Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP. | 7.19e-05 | 3 | 171 | 2 | 11393660 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 15982255 | ||
| Pubmed | HLA class II allele distribution in the Gypsy community of Andalusia, southern Spain. | 7.19e-05 | 3 | 171 | 2 | 11260508 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 16096810 | ||
| Pubmed | Polymorphism of HLA-DRB1, -DQB1 and -DPB1 genes in Bai ethnic group in southwestern China. | 7.19e-05 | 3 | 171 | 2 | 18778327 | |
| Pubmed | Polymorphism of HLA class II genes in Miao and Yao nationalities of Southwest China. | 7.19e-05 | 3 | 171 | 2 | 16441488 | |
| Pubmed | Human leukocyte antigen class II associations with systemic sclerosis in South Africans. | 7.19e-05 | 3 | 171 | 2 | 15104683 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 16453260 | ||
| Interaction | HCST interactions | GEMIN2 STK17B RTTN MTMR1 RNF213 SLC10A7 EXOC8 KLRK1 FOCAD DIP2A MDN1 WDFY3 TBCD | 8.66e-09 | 205 | 158 | 13 | int:HCST |
| Interaction | HLA-B interactions | ABCC1 HLA-DQB1 RTTN RNF213 KLRK1 MDN1 NUP188 SGSM3 WDFY3 VARS1 VCP HTT | 4.20e-07 | 239 | 158 | 12 | int:HLA-B |
| Interaction | TACSTD2 interactions | 8.16e-06 | 129 | 158 | 8 | int:TACSTD2 | |
| Interaction | CTDP1 interactions | 3.83e-05 | 207 | 158 | 9 | int:CTDP1 | |
| Interaction | FMO3 interactions | 3.84e-05 | 9 | 158 | 3 | int:FMO3 | |
| Interaction | OPALIN interactions | 4.13e-05 | 209 | 158 | 9 | int:OPALIN | |
| Interaction | HAVCR2 interactions | 4.84e-05 | 83 | 158 | 6 | int:HAVCR2 | |
| GeneFamily | Solute carriers | SLC26A2 SLC38A4 SLC43A1 SLC13A2 SLC10A7 SLC5A1 SLC22A18 SLC13A4 SLC30A5 SLC45A3 SLCO2A1 SLC22A4 SLC38A3 SLC38A8 | 2.98e-07 | 395 | 118 | 14 | 752 |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 1.26e-04 | 3 | 118 | 2 | 297 | |
| GeneFamily | Dyneins, axonemal | 1.72e-04 | 17 | 118 | 3 | 536 | |
| GeneFamily | Type 2 receptor serine/threonine kinases | 4.17e-04 | 5 | 118 | 2 | 346 | |
| GeneFamily | Mitogen-activated protein kinase kinases | 8.68e-04 | 7 | 118 | 2 | 653 | |
| GeneFamily | Phosphoinositide phosphatases | 1.17e-03 | 32 | 118 | 3 | 1079 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.48e-03 | 9 | 118 | 2 | 1203 | |
| GeneFamily | ATP binding cassette subfamily C | 3.14e-03 | 13 | 118 | 2 | 807 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 3.65e-03 | 14 | 118 | 2 | 1095 | |
| GeneFamily | Rhomboid family | 3.65e-03 | 14 | 118 | 2 | 926 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 4.20e-03 | 15 | 118 | 2 | 903 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | DOCK2 HLA-DPB1 STK17B HLA-DQB1 NEDD9 SIGLEC10 OTULINL ST8SIA4 CPVL | 4.54e-08 | 186 | 171 | 9 | 305f1726b8b5add32f1c29c74991ff34f42e0da7 |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-B_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-07 | 173 | 171 | 8 | a693772987f1baee533dd0bd285a3c7b5619a73b | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.95e-07 | 180 | 171 | 8 | 289f8c4b53ffd164fee1f459a9315c0deb5f76d0 | |
| ToppCell | LAM-Myeloid-DC|LAM / Condition, Lineage and Cell class | GLIPR1 HLA-DPB1 STK17B HLA-DQB1 CORO1A SIGLEC10 OTULINL CPVL | 6.88e-07 | 188 | 171 | 8 | b4140110c2f7d25fd8a0d2749e33e02003ac4bf2 |
| ToppCell | Bronchial_Brush-Immune-Dendritic_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.72e-07 | 194 | 171 | 8 | dbcc00940538efc0f89f074dbe822c50efa5ad8e | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.06e-07 | 195 | 171 | 8 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-DC2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | GLIPR1 HLA-DPB1 STK17B HLA-DQB1 CORO1A SIGLEC10 OTULINL CPVL | 9.06e-07 | 195 | 171 | 8 | 143093edefb3da63bb10adb1f5ea6e250a524ac2 |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.42e-07 | 196 | 171 | 8 | 23e22dfb9f9aec17b83574295f889e75f46ded50 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.42e-07 | 196 | 171 | 8 | 008e7593ab26988b957673f863bdd017516281ae | |
| ToppCell | wk_15-18-Hematologic|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.78e-07 | 197 | 171 | 8 | ecc2f84c1f7442cad668a534e59eccc637dfbf44 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.78e-07 | 197 | 171 | 8 | 57dafb3047745a44b2345b8036e159c3641d496e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.78e-07 | 197 | 171 | 8 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | GLIPR1 HLA-DPB1 STK17B HLA-DQB1 CORO1A SIGLEC10 OTULINL CPVL | 1.02e-06 | 198 | 171 | 8 | f44eb16695ea52e3f99073f5976590069b1d9c5a |
| ToppCell | wk_15-18-Hematologic-Myeloid|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.02e-06 | 198 | 171 | 8 | d5a66ed71b0a4b070b19bc3a1540c741865f3cf1 | |
| ToppCell | 15-Distal-Immune-Hematopoietic,_Macrophage|Distal / Age, Tissue, Lineage and Cell class | 1.02e-06 | 198 | 171 | 8 | 0e4aa6c7d74c5b1bb26996df1be3d58f998d18ac | |
| ToppCell | distal-1-Hematologic-Myeloid_Dendritic_Type_2|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.02e-06 | 198 | 171 | 8 | 5b27949ac3fc7eb34949f9f360d57e6ae82a2368 | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_2-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | GLIPR1 HLA-DPB1 STK17B HLA-DQB1 CORO1A SIGLEC10 OTULINL CPVL | 1.06e-06 | 199 | 171 | 8 | 83400b10974ef4dafe8223562cdcdc58eef92428 |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DOCK2 HLA-DPB1 HLA-DQB1 KEAP1 CORO1A SIGLEC10 UGT2B17 ST8SIA4 | 1.10e-06 | 200 | 171 | 8 | 4f7be296be0cd54cfc62cc93263fde26210c61f4 |
| ToppCell | Bronchus_Control_(B.)-Immune-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.10e-06 | 200 | 171 | 8 | ad0d38ffe5ca138b40823d15b239c2f9f3f0e93c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-06 | 166 | 171 | 7 | 83d0c26ccee605df6b04bbca31661bf4ff4f22ba | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-06 | 169 | 171 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.04e-06 | 174 | 171 | 7 | 5c69447261c5aa309a24882656da90655728d637 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.04e-06 | 174 | 171 | 7 | bdbaf805a94b2f5a0065933dab6bf84e3cabd525 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 184 | 171 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 184 | 171 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 184 | 171 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.53e-06 | 185 | 171 | 7 | a1b2525da018abe458908cab7268bd403ee98d92 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Cycling_DC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.80e-06 | 186 | 171 | 7 | de1f0bc5dbf6dc0e716f5ebbf2bbcfe249811c54 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.80e-06 | 186 | 171 | 7 | 5916ee851c17d6d9adefeea900b4dfa9642982dc | |
| ToppCell | wk_08-11-Hematologic-Myeloid-S100A12-lo_cla._mono.|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.80e-06 | 186 | 171 | 7 | be50f5c7f32b3126442ebff1e7d38aa78b6e4e71 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 8.08e-06 | 187 | 171 | 7 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.66e-06 | 189 | 171 | 7 | 8419d62e6991851bdc6ad861f5c9086ff808b222 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.66e-06 | 189 | 171 | 7 | a010f3e4da6e9bb23b0b9a7f82ad5cee4e607ecd | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 8.66e-06 | 189 | 171 | 7 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.66e-06 | 189 | 171 | 7 | 659deb617a560bcde67c75f477d30ce85aaec3c6 | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.66e-06 | 189 | 171 | 7 | 67f9a9861d2dcc128b7a69432c6b31da185e2249 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-DC2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.96e-06 | 190 | 171 | 7 | 902afe2121593ae08d083c2cea2d1ba9f848574a | |
| ToppCell | 18-Distal-Immune-Hematopoietic,_Macrophage|Distal / Age, Tissue, Lineage and Cell class | 9.59e-06 | 192 | 171 | 7 | e54577183b09599a3b2bdd532a18ea8f4a6e3524 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-06 | 192 | 171 | 7 | ae7513fde6e33a1908c2777cdb1d1e4ead1bcb2f | |
| ToppCell | wk_08-11-Hematologic-Myeloid-CX3CR1+_Mac|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.92e-06 | 193 | 171 | 7 | afc20433b5abc9b430751a2aa8d93b0fd136a888 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.92e-06 | 193 | 171 | 7 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | wk_20-22-Hematologic-Myeloid-DC3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.92e-06 | 193 | 171 | 7 | 12d1e7ed0bcd1259d6dc8ae962aad69586e5d26b | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-05 | 194 | 171 | 7 | 024568d8a862f0fe4da1f66a58c6e71f0e8279f3 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-DC2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.03e-05 | 194 | 171 | 7 | 6a9bb5ad04aba13a4886fa27a96e28e90b6586e3 | |
| ToppCell | PBMC-Severe-Lymphocyte-B|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-05 | 194 | 171 | 7 | bd2c53fb064edfec76abe56a9ffaced0bda32ab0 | |
| ToppCell | PBMC-Severe-Lymphocyte-B|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.03e-05 | 194 | 171 | 7 | 7dbedbdece4271e10134c9338c85cb3e04484c75 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-05 | 194 | 171 | 7 | 74d588de2f84a4ef112fd642f7e112a542d5ef11 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-05 | 194 | 171 | 7 | 59180fe75be386530f1be668a37e4ada2eb19ddc | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-05 | 195 | 171 | 7 | c26c62522b6e0599f6a1256fefe26e1ed9badcc2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-05 | 195 | 171 | 7 | 60ba7be0c333ddc57885263a1103faffe06051c7 | |
| ToppCell | 15-Airway-Immune-Hematopoietic,_Macrophage|Airway / Age, Tissue, Lineage and Cell class | 1.06e-05 | 195 | 171 | 7 | 705aa5442c61d5fdc0aafb2ad40b8c9d2dc566c6 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-05 | 195 | 171 | 7 | 97a9410f47beca02346902d078288a75bfe6e56b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-05 | 195 | 171 | 7 | d67950679ccb508016352e9cb4c675bd09eaac5b | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.06e-05 | 195 | 171 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | proximal-Hematologic-Plasma-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-05 | 196 | 171 | 7 | f6e842b18765c2d923706cabb5d17efeff1da5aa | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-05 | 196 | 171 | 7 | 63b841457d12fb9dd25630e3c348d3ef53463f86 | |
| ToppCell | proximal-3-Hematologic-Plasma|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-05 | 196 | 171 | 7 | 1ca453582b5db8f1ea20a846e698c54edf0a1f25 | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_Macrophage|Airway / Age, Tissue, Lineage and Cell class | 1.10e-05 | 196 | 171 | 7 | f73573b5d9c735f2a2c718472b7d12b10f2a3718 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-05 | 196 | 171 | 7 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-DC3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.10e-05 | 196 | 171 | 7 | 20808c2ce010e4fcda092ecce94487f0afff733b | |
| ToppCell | proximal-Hematologic-Plasma|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-05 | 196 | 171 | 7 | 621f112a71f3d82fd75da8addfb16d86f590fe33 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.10e-05 | 196 | 171 | 7 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 196 | 171 | 7 | fa24d7c4b7c65e98b209db302a16c58ceac1a105 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.10e-05 | 196 | 171 | 7 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.13e-05 | 197 | 171 | 7 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 197 | 171 | 7 | 09a2c0c0f9c2442743414236c2d5c1f27be66e4c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-05 | 197 | 171 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.13e-05 | 197 | 171 | 7 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 197 | 171 | 7 | 49511ea2330a516456007e73bc3195334433011c | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.13e-05 | 197 | 171 | 7 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | distal-3-Hematologic-Myeloid_Dendritic_Type_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-05 | 198 | 171 | 7 | 8e5ac110278461af6eceec1e04de02df8430d1d7 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-05 | 198 | 171 | 7 | 79c8ab15e73f727c5e110ab9eab3ccb5edf9f714 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B|COVID-19_Severe / Disease, condition lineage and cell class | 1.17e-05 | 198 | 171 | 7 | 1831a777dd996c25f637d551d754ec1b9c23feb2 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-05 | 198 | 171 | 7 | 23314bed02edadccdc5da4fa153142a25e4a440e | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.17e-05 | 198 | 171 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-05 | 198 | 171 | 7 | 984b3753fabd5553f6f364f90a422b035e421535 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-05 | 198 | 171 | 7 | 41e8a7894f52f3a5f8f24575b3f6e205429489b2 | |
| ToppCell | ASK452-Immune|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.17e-05 | 198 | 171 | 7 | 47d37a05edd68b73c75bb81a477707413d6464e1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 198 | 171 | 7 | 623f9d64c9e800d2d7f623392bf2f22b563f0249 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 199 | 171 | 7 | 04adf46975aa4194ea40c7480f8a517def5d929c | |
| ToppCell | normal_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.21e-05 | 199 | 171 | 7 | 72c96a5954dfcfbfee8f095984ce1f5249d9a679 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-05 | 199 | 171 | 7 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | 11.5-Distal-Immune-Hematopoietic,_Macrophage|Distal / Age, Tissue, Lineage and Cell class | 1.21e-05 | 199 | 171 | 7 | dd61854de202c805100bad58f1ce08c3bd04bb58 | |
| ToppCell | distal-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-05 | 199 | 171 | 7 | 5e209df67cfe8ac7437cc363f1c5c3166bfae1af | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-05 | 199 | 171 | 7 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-05 | 199 | 171 | 7 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | distal-Hematologic-Intermediate_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-05 | 199 | 171 | 7 | f393f8d2b9711e71beb4f1c5e7cac5acb047fd0e | |
| ToppCell | distal-Hematologic-Intermediate_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-05 | 199 | 171 | 7 | fa362f3e456a4853652e52d54e76473809eea76d | |
| ToppCell | Biopsy_IPF-Immune-cDCs|Biopsy_IPF / Sample group, Lineage and Cell type | 1.25e-05 | 200 | 171 | 7 | f7730e2d3ed14a86141491fd20e3aa562670c757 | |
| ToppCell | Biopsy_IPF-Immune|Biopsy_IPF / Sample group, Lineage and Cell type | 1.25e-05 | 200 | 171 | 7 | 31067dcf63030144679fca20fa41d665cb0035b7 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM-MoAM-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-05 | 200 | 171 | 7 | 390f9429feae991b8524e2815d8fcd4914c74459 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.25e-05 | 200 | 171 | 7 | fe27d56a05151049a64e35db5a144ff7952e6902 | |
| ToppCell | Biopsy_Other_PF-Immune|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.25e-05 | 200 | 171 | 7 | 78b35f7afe4a3ebacf115c6d9c873e697bcbd2df | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.25e-05 | 200 | 171 | 7 | f7e9b4a8ededb116774528b38ea3381b6f05915c | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 200 | 171 | 7 | 8441e289377215a6877640946fe3f6de1f456502 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.25e-05 | 200 | 171 | 7 | d98c523ac0e4767aaeef50cae142513d115212ab | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.25e-05 | 200 | 171 | 7 | 59b2ebb69699c9bebf8c2697eb678fdccd0a998c | |
| ToppCell | Biopsy_Control_(H.)-Immune|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.25e-05 | 200 | 171 | 7 | e1d50556ca116ef4b65ec29ab2ef7341f0d21451 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 200 | 171 | 7 | 7cb3e3bd9e851ccb096e0a3471819471d85ebace | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3-Excitatory_Neuron.Slc17a7.Pvrl3-Fos_(CA3_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.43e-05 | 80 | 171 | 5 | b661644806e225f215047e78ae46d7cee6efde4f | |
| Drug | zinc methionine | 1.60e-06 | 4 | 169 | 3 | ctd:C074508 | |
| Disease | cervical cancer (is_implicated_in) | 2.31e-05 | 30 | 165 | 4 | DOID:4362 (is_implicated_in) | |
| Disease | Situs ambiguus | 7.44e-05 | 15 | 165 | 3 | C0266642 | |
| Disease | cholic acid glucuronide measurement | 9.29e-05 | 3 | 165 | 2 | EFO_0800574 | |
| Disease | myocarditis (is_implicated_in) | 9.29e-05 | 3 | 165 | 2 | DOID:820 (is_implicated_in) | |
| Disease | high altitude adaptation | 1.10e-04 | 17 | 165 | 3 | EFO_0009105 | |
| Disease | Moyamoya Disease | 1.10e-04 | 17 | 165 | 3 | C0026654 | |
| Disease | pneumonia | 1.39e-04 | 47 | 165 | 4 | EFO_0003106 | |
| Disease | X-25937 measurement | 1.85e-04 | 4 | 165 | 2 | EFO_0800937 | |
| Disease | Jeune thoracic dystrophy | 1.85e-04 | 4 | 165 | 2 | cv:C0265275 | |
| Disease | tropical spastic paraparesis (is_implicated_in) | 1.85e-04 | 4 | 165 | 2 | DOID:321 (is_implicated_in) | |
| Disease | worry measurement | 2.37e-04 | 154 | 165 | 6 | EFO_0009589 | |
| Disease | Morbilliform Drug Reaction | 2.80e-04 | 23 | 165 | 3 | C0406537 | |
| Disease | Drug Eruptions | 2.80e-04 | 23 | 165 | 3 | C0011609 | |
| Disease | autosomal recessive osteopetrosis 1 (implicated_via_orthology) | 3.07e-04 | 5 | 165 | 2 | DOID:0110942 (implicated_via_orthology) | |
| Disease | Kohlschutter-Tonz syndrome (implicated_via_orthology) | 3.07e-04 | 5 | 165 | 2 | DOID:0111668 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 3.21e-04 | 163 | 165 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Ciliopathies | 3.92e-04 | 110 | 165 | 5 | C4277690 | |
| Disease | Angioedema | 4.59e-04 | 6 | 165 | 2 | C0002994 | |
| Disease | Graft-vs-Host Disease | 4.59e-04 | 6 | 165 | 2 | C0018133 | |
| Disease | response to vaccine | 6.30e-04 | 122 | 165 | 5 | EFO_0004645 | |
| Disease | narcolepsy (is_implicated_in) | 6.41e-04 | 7 | 165 | 2 | DOID:8986 (is_implicated_in) | |
| Disease | Nephronophthisis, familial juvenile | 6.41e-04 | 7 | 165 | 2 | C1855681 | |
| Disease | Senior-Loken syndrome (is_implicated_in) | 6.41e-04 | 7 | 165 | 2 | DOID:0050576 (is_implicated_in) | |
| Disease | X-24574 measurement | 6.41e-04 | 7 | 165 | 2 | EFO_0800897 | |
| Disease | Renal dysplasia and retinal aplasia | 6.41e-04 | 7 | 165 | 2 | cv:C0403553 | |
| Disease | isovalerylcarnitine measurement | 6.41e-04 | 7 | 165 | 2 | EFO_0020019 | |
| Disease | waist circumference | 7.28e-04 | 429 | 165 | 9 | EFO_0004342 | |
| Disease | alcohol-related neurodevelopmental disorder (implicated_via_orthology) | 8.51e-04 | 8 | 165 | 2 | DOID:0050667 (implicated_via_orthology) | |
| Disease | deoxycholic acid glucuronide measurement | 8.51e-04 | 8 | 165 | 2 | EFO_0800575 | |
| Disease | renal tubular acidosis (implicated_via_orthology) | 8.51e-04 | 8 | 165 | 2 | DOID:14219 (implicated_via_orthology) | |
| Disease | serum metabolite measurement | RALGAPA1 ABCC1 HLA-DPB1 TMEM235 PKD1L2 SACM1L IVD SLC22A4 DNAH17 SYNE2 FSHR UGT2B15 AGBL1 EPHA10 | 8.97e-04 | 945 | 165 | 14 | EFO_0005653 |
| Disease | small cell lung carcinoma | 1.07e-03 | 80 | 165 | 4 | EFO_0000702 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 1.09e-03 | 9 | 165 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | Situs ambiguous | 1.09e-03 | 9 | 165 | 2 | C1167664 | |
| Disease | hepatitis B (is_implicated_in) | 1.16e-03 | 37 | 165 | 3 | DOID:2043 (is_implicated_in) | |
| Disease | Drug toxicity | 1.28e-03 | 84 | 165 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 1.28e-03 | 84 | 165 | 4 | C0041755 | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 1.34e-03 | 85 | 165 | 4 | DOID:9744 (is_implicated_in) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Marfan syndrome (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:14323 (implicated_via_orthology) | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 1.36e-03 | 10 | 165 | 2 | EFO_0022090 | |
| Disease | CCL19 measurement | 1.36e-03 | 10 | 165 | 2 | EFO_0009415 | |
| Disease | factor VIII measurement | 1.46e-03 | 40 | 165 | 3 | EFO_0004630 | |
| Disease | prostate carcinoma | DOCK2 SYNJ2BP HLA-DQB1 RNF213 ACVR2A TEX11 MMP25 NEDD9 GCLC SYNE2 MAP2K1 CPVL EPHA10 | 1.57e-03 | 891 | 165 | 13 | EFO_0001663 |
| Disease | Jeune thoracic dystrophy | 1.65e-03 | 11 | 165 | 2 | C0265275 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 1.65e-03 | 11 | 165 | 2 | EFO_0801531 | |
| Disease | Situs Inversus | 1.65e-03 | 11 | 165 | 2 | C0037221 | |
| Disease | Night blindness, congenital stationary, type 1 | 1.98e-03 | 12 | 165 | 2 | C3501847 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.98e-03 | 12 | 165 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 1.98e-03 | 12 | 165 | 2 | C0403553 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 1.98e-03 | 12 | 165 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 1.98e-03 | 12 | 165 | 2 | C1864877 | |
| Disease | Gastrointestinal Diseases | 1.98e-03 | 12 | 165 | 2 | C0017178 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.98e-03 | 12 | 165 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Huntington Disease, Late Onset | 1.98e-03 | 12 | 165 | 2 | C0393574 | |
| Disease | Functional Gastrointestinal Disorders | 1.98e-03 | 12 | 165 | 2 | C0559031 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 1.98e-03 | 12 | 165 | 2 | C1850362 | |
| Disease | Cholera Infantum | 1.98e-03 | 12 | 165 | 2 | C1565321 | |
| Disease | X-Linked Csnb | 1.98e-03 | 12 | 165 | 2 | C3711543 | |
| Disease | waist-hip ratio, body mass index | 1.98e-03 | 12 | 165 | 2 | EFO_0004340, EFO_0004343 | |
| Disease | Akinetic-Rigid Variant of Huntington Disease | 1.98e-03 | 12 | 165 | 2 | C0751207 | |
| Disease | Juvenile Huntington Disease | 1.98e-03 | 12 | 165 | 2 | C0751208 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 1.98e-03 | 12 | 165 | 2 | C1848172 | |
| Disease | Congenital myopathy (disorder) | 1.98e-03 | 12 | 165 | 2 | C0270960 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 1.98e-03 | 12 | 165 | 2 | EFO_0800291 | |
| Disease | Celiac Disease | 2.32e-03 | 47 | 165 | 3 | C0007570 | |
| Disease | liver cirrhosis (implicated_via_orthology) | 2.33e-03 | 13 | 165 | 2 | DOID:5082 (implicated_via_orthology) | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 2.33e-03 | 13 | 165 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 2.33e-03 | 13 | 165 | 2 | C4041558 | |
| Disease | juvenile rheumatoid arthritis (is_implicated_in) | 2.33e-03 | 13 | 165 | 2 | DOID:676 (is_implicated_in) | |
| Disease | autoimmune hepatitis (is_implicated_in) | 2.33e-03 | 13 | 165 | 2 | DOID:2048 (is_implicated_in) | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 2.33e-03 | 13 | 165 | 2 | EFO_0800293 | |
| Disease | X-19141 measurement | 2.33e-03 | 13 | 165 | 2 | EFO_0800799 | |
| Disease | Nephronophthisis | 2.33e-03 | 13 | 165 | 2 | C0687120 | |
| Disease | Mitochondrial disease | 2.62e-03 | 49 | 165 | 3 | cv:C0751651 | |
| Disease | rostral middle frontal gyrus volume measurement | 2.71e-03 | 14 | 165 | 2 | EFO_0010328 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 2.71e-03 | 14 | 165 | 2 | EFO_0800283 | |
| Disease | Alzheimer disease, educational attainment | 2.74e-03 | 247 | 165 | 6 | EFO_0011015, MONDO_0004975 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 2.78e-03 | 50 | 165 | 3 | EFO_0010732 | |
| Disease | Crohn Disease | 2.78e-03 | 50 | 165 | 3 | C0010346 | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 3.10e-03 | 52 | 165 | 3 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | liver neoplasm | 3.11e-03 | 15 | 165 | 2 | EFO_1001513 | |
| Disease | Replication Error Phenotype | 3.11e-03 | 15 | 165 | 2 | C1721098 | |
| Disease | Microsatellite Instability | 3.11e-03 | 15 | 165 | 2 | C0920269 | |
| Disease | Lymphoma, Follicular, Grade 2 | 3.11e-03 | 15 | 165 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 3.11e-03 | 15 | 165 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 3.11e-03 | 15 | 165 | 2 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 3.11e-03 | 15 | 165 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 3.11e-03 | 15 | 165 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 3.11e-03 | 15 | 165 | 2 | C0079758 | |
| Disease | N-acetylmethionine measurement | 3.11e-03 | 15 | 165 | 2 | EFO_0021427 | |
| Disease | Urticaria | 3.54e-03 | 16 | 165 | 2 | C0042109 | |
| Disease | gastroparesis | 3.54e-03 | 16 | 165 | 2 | EFO_1000948 | |
| Disease | sickle cell anemia (is_implicated_in) | 3.54e-03 | 16 | 165 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | lymphocyte count | DOCK2 ABCC1 TRIB2 HLA-DQB1 KEAP1 ITPR1 FOCAD DIP2A SLC45A3 STAG3L1 SLC22A4 DNAH17 STAG3L2 MICAL3 ST8SIA4 VARS1 HTT | 3.55e-03 | 1464 | 165 | 17 | EFO_0004587 |
| Disease | waist-hip ratio | TRIB2 IPO8 NUP85 DYNC2H1 SLC43A1 PSMD12 REEP3 BCDIN3D NEDD9 ABCB9 DNAH17 SYNE2 SCN4A MAP2K3 HTT | 3.79e-03 | 1226 | 165 | 15 | EFO_0004343 |
| Disease | Huntington Disease | 4.00e-03 | 17 | 165 | 2 | C0020179 | |
| Disease | immature granulocyte count | 4.00e-03 | 17 | 165 | 2 | EFO_0803542 | |
| Disease | Night blindness, congenital stationary | 4.00e-03 | 17 | 165 | 2 | C0339535 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MIWRSRAGAELFSLM | 1 | Q76B58 | |
| VLEMRGTAAGMDLWV | 1151 | Q8WWN8 | |
| SARVDEPMTMFLWTL | 1131 | Q2NKJ3 | |
| EMGVSSLMALVTTDW | 421 | Q14511 | |
| VSWLTTMMGLRLQVV | 911 | P46379 | |
| LMERQAVTFEGTDMW | 716 | O75815 | |
| SVFDIGFCMSITMWI | 156 | Q7Z5W3 | |
| DMYAMGLVLWELASR | 386 | P27037 | |
| VAFTEVMGMLWRRLN | 51 | Q9H201 | |
| NGLVLWMTVFRMART | 61 | O75388 | |
| RNGDWTFQILVMLEM | 176 | P04440 | |
| MAWMETVATISASRL | 206 | Q8WYK0 | |
| VTQMALWAIMAAPLF | 281 | P06280 | |
| IMVWDVGTGAAMLTL | 156 | P31146 | |
| TWMTAVGLSEMAAEA | 156 | Q9NR28 | |
| GQALMAMLVYVWSRR | 121 | Q96Q80 | |
| VVVWREMGVSRSYTM | 971 | Q96MI9 | |
| IWSMGLSLVEMAVGR | 246 | Q02750 | |
| GWDRTAQLTSLAMLM | 441 | Q13613 | |
| MMRAVWEALAALAAV | 1 | O95631 | |
| WFPRMRAMSLVSNEG | 2601 | Q14573 | |
| VDTRWRYMLMIFSAA | 51 | P48050 | |
| MAVTAAVLFEMVQGW | 1391 | O75140 | |
| ETVRVLMSYALMAWG | 136 | Q9NPA2 | |
| LMAWGMESGLTFHEV | 146 | Q9NPA2 | |
| RMRKDWFMVGIVLAI | 6 | Q0GE19 | |
| FLEGLWMIMNDRLTE | 161 | Q6NXN4 | |
| EMATTEVLKRLGMWT | 326 | P42898 | |
| MNRGVFMKLVIFSWI | 136 | P58181 | |
| FTWSLGAEMVLFTTM | 101 | Q8NGZ3 | |
| DFLLKAIMRTMWFAG | 96 | Q8NF37 | |
| IARGFLAAMDSAWMV | 411 | Q7RTP6 | |
| GHIVWTEGMRRLAML | 1361 | Q9NU22 | |
| MRVTLATIAWMVSFV | 1 | P48060 | |
| MRRAELAGLKTMAWV | 1 | O14893 | |
| HAVMGIWMVSFILST | 136 | Q16538 | |
| DWFPRMRAMSLVSSD | 2681 | Q14643 | |
| RVVMNSREFGIWMLE | 61 | A8MUM7 | |
| MTNMSWSFLTRLLEE | 1 | Q5T442 | |
| RFVLASRLQSDWMLM | 631 | Q5T848 | |
| RTTDVAMLVTMFGWF | 201 | Q9BY71 | |
| SDAILVLATSMWMAF | 6 | P0C7L1 | |
| WSLLTMGMTQLRIIF | 306 | O75387 | |
| MASALWTVLPSRMSL | 1 | O75752 | |
| LLLSMGGTWASREML | 11 | P0DN87 | |
| VAAALTERSLMGMDW | 391 | Q9H3G5 | |
| LSLMTSRIAPRSFWM | 561 | Q9BW27 | |
| TVMEFLLMRFSDVWT | 6 | Q8NHC7 | |
| AGLTLMWNREDALML | 141 | Q02817 | |
| WREFRTLVIEMVMAT | 326 | Q14123 | |
| VLMESLTQFLGWSVM | 416 | P35913 | |
| VAMGIRFIIMVTIWS | 61 | P26718 | |
| MSRFLNVLRSWLVMV | 1 | Q9UKR5 | |
| ASGELMTVARWMREF | 566 | P48506 | |
| MVARVWSLMRFLIKG | 1 | Q5XKP0 | |
| RDSWNAGIMTVMSAL | 81 | Q5XKP0 | |
| HRIFWLITGIMFMGS | 371 | Q9HD23 | |
| MFMGSGLIWRRLLSF | 381 | Q9HD23 | |
| VMDYIVSTWSMSRGI | 536 | O95259 | |
| WDRTAQLTSLAMLML | 421 | Q13614 | |
| LAMMWFISTLAETNR | 181 | P03886 | |
| MGIMAASRPLSRFWE | 1 | Q6P587 | |
| MRSSLTMVGTLWAFL | 1 | Q86WI0 | |
| LKLFTTMELMRWSTL | 306 | O00232 | |
| TMELMRWSTLVEDYG | 311 | O00232 | |
| SFGIIMWEVMAFGER | 831 | Q5JZY3 | |
| FLEGLWMIMNDRLTE | 166 | Q6NUT2 | |
| MAEMATATRLLGWRV | 1 | P26440 | |
| VWARSAMGMFVDAFS | 491 | Q8IYI6 | |
| MRRMWATQGLAVALA | 1 | P55145 | |
| SIIFGMASMVAFWLS | 311 | Q8TDS5 | |
| ALDTVWRMAKGFVML | 36 | Q9NUU6 | |
| WRMAKGFVMLAVSFL | 41 | Q9NUU6 | |
| WQEVMIGLESSILMF | 1591 | Q7Z442 | |
| LRLMGIFDTSWVSMK | 3021 | Q8NCM8 | |
| RNGDWTFQILVMLEM | 181 | P01920 | |
| MATMILTLLSSAWFP | 1066 | P42858 | |
| TGQSSMVRDWVMLSL | 3026 | P42858 | |
| MYDLMEWRSQLLSGT | 121 | Q92608 | |
| SVFPRDWMVMRLLTS | 991 | Q8IZD9 | |
| MTGYEARLITFGTWM | 1 | Q96P09 | |
| TWVARAYPSMMGLAA | 4281 | Q9UFH2 | |
| LMFVAWMTTVSIGVL | 376 | Q6ZNA5 | |
| IAMTAGWLVLAIAMV | 81 | B0YJ81 | |
| IDVWAVGSIMAELYM | 181 | P20794 | |
| IAEMAIIWLSMRGGI | 71 | Q9Y4D2 | |
| EWRMITAMNTIRSGA | 496 | Q14145 | |
| WRQLMQATGVSFTMD | 1386 | Q9NYC9 | |
| AGLWHGVLTSVMNRM | 561 | Q14689 | |
| VQLRHAASVMVMGWI | 481 | P23945 | |
| MFSSVMRLELSKWGI | 241 | P37059 | |
| LMAWMDLFITQGATI | 336 | O00237 | |
| LGFMLVTAFLSMWIS | 126 | Q13183 | |
| EMVTGFFFILMTVLW | 376 | Q9UKG4 | |
| THLGLIMDGWNSMIR | 466 | Q9NTJ5 | |
| ISWEMFTVLFVIVGM | 191 | Q9H015 | |
| MAAVSMSVVLRQTLW | 1 | O43181 | |
| MYGTIFTAWRILEVM | 411 | Q5VW36 | |
| SRNGMVFMSSSILDW | 2391 | Q8TE73 | |
| MPSQLAFRDLMWDAT | 356 | O15259 | |
| MAIGNWTEISEFILM | 1 | Q9H207 | |
| FLVLSLWGMIMTSSI | 261 | P03905 | |
| MTTWMEIFRTIIDRT | 226 | O15397 | |
| VWSLGITMIEMAILR | 251 | P46734 | |
| WLVRMSSEMETNIVA | 1246 | P33527 | |
| RLMMTALTWNKFIES | 701 | Q86VV8 | |
| TGHDILFFWVARMVM | 821 | P26640 | |
| FEEFIMLMARLTWAS | 76 | P06702 | |
| LMTMSLSFIIIDWAS | 481 | Q99624 | |
| IWSIGVVMYMLLRGE | 306 | Q9BYT3 | |
| SLLQVATFKGWMDIM | 1236 | P35499 | |
| LDSMWGMLRARYTEL | 4716 | Q8WXH0 | |
| ALICMSMEFGRAVWL | 311 | P58872 | |
| VLMFFSRASVWMSED | 51 | Q8WWF3 | |
| PVFALTMVAAWAFMR | 126 | P57105 | |
| SFGILMWEVMSYGER | 846 | O15197 | |
| FWMMSAIIEDLLPAS | 221 | Q96HU1 | |
| TDMWNIGIIAYMLLT | 216 | O94768 | |
| REMFSVGGLFWMFRI | 186 | Q96K19 | |
| SMLNDSVLWIPAFMV | 216 | Q92187 | |
| LTLAGHIEWERTMML | 736 | Q8WX94 | |
| MVWSEAMARGSFLNA | 116 | A3QJZ7 | |
| MRDQMSFLLWSKVGS | 96 | Q8NEZ3 | |
| QMEWSITGMLEFSLF | 611 | P14410 | |
| LELFTGRFKDWMVSM | 81 | P0CL83 | |
| MIGSMALIIIDWIYD | 526 | Q969I6 | |
| TILWVTVTLAMALFM | 351 | A6NNN8 | |
| MAFLRSMWGVLSALG | 1 | Q00059 | |
| ALRWFALRMDVLMNI | 1021 | Q96J65 | |
| LWQVLERTFMRDTIM | 1226 | Q96J65 | |
| MVSWMISRAVVLVFG | 1 | Q6NUK4 | |
| SVLVFIVVGLAMAWM | 311 | Q96BI1 | |
| IVVGLAMAWMSSVFH | 316 | Q96BI1 | |
| VAELCSWMALMTFTL | 276 | Q96JT2 | |
| MRLWKAVVVTLAFMS | 1 | Q9NP78 | |
| MYAMGLVLWELVSRC | 386 | Q13705 | |
| TSSMWGLMVVAQLLA | 166 | Q92959 | |
| ADILVWSETTMGMAI | 291 | Q53QW1 | |
| LHSAGNMLFRTWIAM | 1626 | Q63HN8 | |
| ARDLWMFIFSDTMLL | 3661 | Q63HN8 | |
| KWASDLRLTGRLMFM | 161 | Q9Y3V2 | |
| LFPLTLVRSFWSDMM | 141 | Q9BXS4 | |
| GTWEVFINLRSMMIS | 166 | I1YAP6 | |
| WAMVSLCIVFAMTSG | 231 | Q13454 | |
| GLEAEARMTTWHIMI | 2161 | Q8IZQ1 | |
| HMQGVRVSFGWSMAL | 166 | A6NFC5 | |
| ATVMWRRMLGILGDV | 1061 | Q6GYQ0 | |
| VMNSLAVTMDDFRWA | 441 | P55072 | |
| SISRMDTVIWFVTML | 506 | P50443 | |
| GETWMRQIISFDRMK | 186 | Q9Y458 | |
| SIFWGMDMVILAISQ | 116 | Q69YW2 | |
| DVWSLGVMLYTMLVG | 236 | Q92519 | |
| ERGEVMNLLMFLSTW | 556 | P24928 | |
| SQMLTAISRMIDWVS | 261 | Q9P2H5 | |
| RMETLTGLRMALNSW | 231 | A2RTY3 | |
| LTSLMRWIAFAVMIV | 236 | Q8NE00 | |
| SLLEYQMLVSAWRML | 1096 | Q5SRE5 | |
| LMVKSWNTGVLMFSR | 866 | Q8IYF3 | |
| LELFTGRFKDWMVSM | 81 | P0CL84 | |
| GSLMSVWVTVIAMAR | 301 | A6NDV4 | |
| FAFGLTLWEMMTLSI | 231 | Q96KB5 | |
| GRMWLLEIFMAAVST | 4221 | Q86WI1 | |
| EAMRIWMDVIVTGAE | 1356 | Q86UU1 | |
| RMWDAVLYRMSVAEA | 251 | A8MZF0 | |
| KMAVFLWQRGEESMA | 626 | Q7Z4N2 | |
| MTLFAVWMVLRESRI | 416 | Q93050 | |
| GMNILFSSWAVVLMV | 11 | Q6GV28 | |
| FSSWAVVLMVMGITL | 16 | Q6GV28 | |
| ELMAWMRNVLGSRVT | 581 | Q12931 | |
| MGLFAALMSRWKATR | 461 | Q8TAD4 | |
| GWSFLAMFRLMTQDS | 346 | Q9UI33 | |
| DVGTWVRKAAMTSLM | 866 | Q9BTW9 | |
| VLGIIVMASTNSLMW | 71 | Q69YG0 | |
| TLFETMGKAEMWLIR | 246 | P54855 | |
| IMRWFGLVSRTVMHC | 126 | Q8N7C4 | |
| FVVVMAVGLWAMFST | 36 | P13866 | |
| AMDGRFWIRVQESVM | 16 | Q96LC7 | |
| WSESMLQRVLHLIGM | 916 | Q8IWV8 | |
| TRRFGQFWMVTMDDP | 561 | Q9Y334 | |
| TLFETMGKAEMWLIR | 246 | O75795 | |
| WAMLMRVGLRVDTTY | 771 | Q9Y487 | |
| WLTETGMALLRNLTM | 1591 | O14686 | |
| VYGTALSMWVSLMAL | 71 | A6NI61 |